Professional physician network Doximity hit two milestones this spring: membership hit 160,000 US physicians and the network released an iPad app that will help doctors better leverage the network
A prescription morning sickness drug combining doxylamine succinate and pyridoxine hydrochloride is returning to US pharmacies after a 30-year absence.
There’s been a paradigm shift among buy-side companies, which have finally accepted the fact that external R&D is going to be a big part of the future.
As doctors’ needs evolve, message delivery must align more with their preferences. Mark Grove and Joanne Flynn share a fresh approach for meeting the challenges of physician engagement
As consumer mHealth apps have become more plentiful, Joe Shields asks whether we’ve all gone “app-crazy,” or if apps have a real role to play in biopharma marketing and customer service
Therapeutic Focus 2013: Infectious Diseases
May 31, 2013
4:00 am
Science is yielding all-oral therapies that can cure hepatitis C in three months, without injected interferon. But there are potential headwinds. Noah Pines sorts out the leaders in hep. C and the rest of the pipeline